Hunter Holmes McGuire VA Medical Center

Richmond, Virginia 23249-0001

4 studies enrolling now · 76 studies all time

What they study most

Accidental Falls, Acute Pain, Acute Renal Failure, Age Related Osteoporosis, Alcohol Abuse, Alcohol Use Disorder, Amputation, Ascites Hepatic, Atrial Fibrillation, Barrett Esophagus, COPD, Cannabis Dependence

Studies at this site

• Intestinal Microbiota Transplant in Alcohol-Associated Liver Disease — Recruiting now
• Microbiome Modulation With Prebiotics in PTSD and Cirrhosis — Recruiting now
• Hepatic Encephalopathy and Albumin Lasting Cognitive Improvement — Recruiting now
• Epidural Stimulation and Resistance Training After SCI — Recruiting now
• A Phase 3 Study to Evaluate the Effect of Resmetirom on Clinical Outcomes in Patients With Well-compensated NASH Cirrhosis (MAESTRO-NASH-OUTCOMES) — Running, not enrolling
• Study Evaluating the Efficacy and Safety of Belapectin for the Prevention of Esophageal Varices in NASH Cirrhosis — Stopped early
• Cryotherapy for Locally Advanced Esophageal Cancer — Running, not enrolling
• Oral Health In Cirrhosis of the Liver (ORACLE) — Running, not enrolling
• Efficacy, Safety and Economic Benefits of Topical Wound Oxygen Therapy in the Treatment of Chronic Diabetic Foot Ulcers — Completed
• BI 655130 Long-term Treatment in Patients With moderate-to Severe Ulcerative Colitis — Completed
• BI655130 (SPESOLIMAB) Induction Treatment in Patients With Moderate-to-severe Ulcerative Colitis — Completed
• Health IT Generated PROs to Improve Outcomes in Cirrhosis — Completed
• CAN-2409 Plus Prodrug With Standard of Care Immune Checkpoint Inhibitor for Stage III/IV NSCLC — Running, not enrolling
• Phase 3 Study of ProstAtak® Immunotherapy With Standard Radiation Therapy for Localized Prostate Cancer — Running, not enrolling
• Randomized Controlled Trial of CAN-2409 Immunotherapy During Active Surveillance for Prostate Cancer (ULYSSES) — Running, not enrolling
• A Phase 2b Study of Icosabutate in Fatty Liver Disease — Completed
• Effect of Brief Dietary Intervention on Ammonia Levels — Completed
• Longitudinal Monitoring of Stool Characteristics — Completed
• Longitudinal Monitoring of Inflammation in Cirrhosis — Completed
• A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of BFKB8488A Compared With Placebo in Participants With Non-Alcoholic Steatohepatitis — Stopped early
• Does Gabapentin and Lamotriginel Have Significantly Fewer Side-effects While Providing Equal or Better Seizure Control Than the Current Drug Choice, Carbamazepine, for the Treatment of Seizures in the Elderly. — Completed
• Strategic MAnagement to Optimize Response To Cardiac Resynchronization Therapy Registry — Completed
• Rifamycin in Minimal Hepatic Encephalopathy — Completed
• Safety and Efficacy of Abaloparatide-SC in Men With Osteoporosis (ATOM) — Completed
• Fecal Transplant in Recurrent Hepatic Encephalopathy — Completed
• EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Preserved Ejection Fraction (EMPEROR-Preserved) — Completed
• HEAL STUDY (Hepatic Encephalopathy and Albumin Study) — Completed
• Phase 3 Study to Evaluate the Efficacy and Safety of Elafibranor Versus Placebo in Patients With Nonalcoholic Steatohepatitis (NASH) — Stopped early
• Exoskeleton and Spinal Cord Injury — Completed
• Postoperative Peripheral Nerve Stimulation for Management of Post-amputation Pain — Completed
• Continuous Infusion Terlipressin for Patients With Cirrhosis and Refractory Ascites — Completed
• Oral Fecal Transplant in Cirrhosis — Completed
• EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Reduced Ejection Fraction (EMPEROR-Reduced) — Completed
• Skeletal Muscle Hypertrophy and Cardio-Metabolic Benefits After Spinal Cord Injury — Completed
• Rifaximin in Minimal Hepatic Encephalopathy — Completed
• Fecal Microbial Transplant for Alcohol Misuse in Cirrhosis — Completed
• Detecting PNES With Single-channel sEMG — Status unconfirmed
• Epidural Stimulation After Spinal Cord Injury — Status unconfirmed
• Stereotactic Body Radiation Therapy in Treating Patients With Low- and Intermediate-Risk Prostate Cancer — Stopped early
• Sorafenib and Vorinostat in Treating Patients With Advanced Liver Cancer — Completed
• The Efficacy of Familiar Voice Stimulation During Coma Recovery — Completed
• Phase 2 Study to Evaluate LUM001 in Combination With Ursodeoxycholic Acid in Patients With Primary Biliary Cirrhosis — Completed
• An Open-label Study to Evaluate the Long-term Safety and Tolerability of LUM001 in Patients With Primary Biliary Cirrhosis — Withdrawn before enrolling
• Neurobehavioral Measurement of Substance Users in Outpatient Treatment Setting — Completed
• Proton Pump Inhibitors and Dysbiosis in Cirrhosis — Completed
• Confocal Endomicroscopy for Permeability of Esophageal Wall in Refractory Gastroesophageal Reflux Disease (GERD) — Status unconfirmed
• Exercise to Reduce Obesity in Spinal Cord Injury — Completed
• Pilot Synovial Fluid Molecular/Stem Cell Response to PRP in Knee Osteoarthritis: Clinical & Imaging Outcome Correlation — Completed
• Glycemic Control and Complications in Diabetes Mellitus Type 2 (VADT) — Completed
• Mindfulness and Support Group to Improve Patient and Caregiver Burden in Cirrhosis — Completed